dividends
NASDAQ · GSK
GSK plc
Healthcare · Drug Manufacturers - General
$50.82
Up+$0.55 (+1.09%)
Updated Aug 31, 2026, 8:50 AM
SID Score
6.7/10
Composite research score
Smart Money
56/100
Neutral
- Market cap
- 99.39B
- P/E ratio
- 13.41
- Dividend yield
- 3.30%
- 52-week range
- $38.63 – $61.70
- Volume
- 3.43M
- Avg. volume
- 5.18M
Price performance
GSK price history
1M range · 20 trading sessions · Daily adjusted prices
GSK closed at $50.82 after 20 trading sessions, down 1.34% for the selected period.
- Last close
- $50.82
- Period change
- -1.34%
- Period low
- $49.52
- Period high
- $52.96
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $50.22 | $50.88 | $49.95 | $50.82 | 3.43M |
| Aug 27, 2026 | $50.945 | $51.03 | $50.165 | $50.27 | 2.47M |
| Aug 26, 2026 | $51.90 | $52.09 | $51.40 | $51.43 | 1.72M |
| Aug 25, 2026 | $51.57 | $52.21 | $51.51 | $52.07 | 2.7M |
| Aug 24, 2026 | $51.54 | $51.9491 | $51.40 | $51.78 | 2.89M |
| Aug 21, 2026 | $51.35 | $52.57 | $51.35 | $52.41 | 2.4M |
| Aug 20, 2026 | $52.57 | $52.63 | $51.86 | $51.96 | 3.6M |
| Aug 19, 2026 | $51.40 | $52.945 | $51.35 | $52.88 | 3.9M |
| Aug 18, 2026 | $50.76 | $51.3531 | $50.65 | $51.15 | 2.83M |
| Aug 17, 2026 | $49.93 | $50.365 | $49.875 | $50.28 | 2.81M |
| Aug 14, 2026 | $49.04 | $49.57 | $48.8603 | $49.52 | 3.72M |
| Aug 13, 2026 | $50.56 | $50.63 | $50.18 | $50.45 | 2.69M |
| Aug 12, 2026 | $50.11 | $50.47 | $49.8604 | $50.30 | 4.09M |
| Aug 11, 2026 | $51.95 | $52.355 | $50.90 | $50.90 | 2.92M |
| Aug 10, 2026 | $51.53 | $52.195 | $51.47 | $52.16 | 3.14M |
| Aug 7, 2026 | $52.71 | $53.085 | $52.42 | $52.96 | 2.52M |
| Aug 6, 2026 | $52.44 | $52.57 | $51.885 | $52.17 | 2.51M |
| Aug 5, 2026 | $52.06 | $52.12 | $51.36 | $51.46 | 2.48M |
| Aug 4, 2026 | $51.47 | $51.705 | $50.93 | $51.53 | 4.56M |
| Aug 3, 2026 | $52.10 | $52.27 | $51.045 | $51.51 | 4.53M |
Latest GSK news
The latest Smart Investors Daily articles mentioning GSK.
Stock researchCompany · Earnings
Loading stock research…